1. Home
  2. TANH vs XBIO Comparison

TANH vs XBIO Comparison

Compare TANH & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$0.99

Market Cap

6.3M

Sector

N/A

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.24

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
XBIO
Founded
2001
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TANH
XBIO
Price
$0.99
$2.24
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
33.5K
35.0K
Earning Date
05-15-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.88
N/A
Revenue
$41,982,988.00
$2,858,935.00
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
$0.19
N/A
Revenue Growth
N/A
13.30
52 Week Low
$0.92
$1.90
52 Week High
$10.77
$13.93

Technical Indicators

Market Signals
Indicator
TANH
XBIO
Relative Strength Index (RSI) 41.26 39.22
Support Level $0.98 $1.90
Resistance Level $1.13 $2.29
Average True Range (ATR) 0.08 0.16
MACD 0.01 0.02
Stochastic Oscillator 36.73 40.55

Price Performance

Historical Comparison
TANH
XBIO

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: